drugset / Trial / NCT03561441

Summary

Aggressive hydration of lactated Ringer's solution has shown considerable beneficial effect in preventing post-ERCP(endoscopic retrograde cholangiopancreatography) pancreatitis. But the occurence rate of post-ERCP pancreatitis are near 10% and there are severe complications of aggressive hydration due to hypervolemia such pulmonary and peripheral edema, prolonged hospital stay and increased medical expense. Also there are no definite guidelines that suggest the duration and amount of hydration. This study evaluates the efficacy and safety of tailored hydration depending on each patient's condition that indicates the likelihood of developing post-ERCP pancreatitis.

Timeline

Start
2019-01-01
Primary completion
2022-01-31
Completion
2023-10-04

Outcome

Met primary endpoint

paper relative risk 0.37, 95% confidence interval 0.15-0.93, P = 0.03 PMID 38912692 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject lactated Ringer's solution Unknown 1.5 ml —
Subject lactated Ringer's solution Unknown 3 ml —

Indications